Search Results
Search results for "assay development"
Results found for "assay development"
- Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors
As a result, there is an ongoing need to develop novel approaches to monitor and to modulate GPCR activation
- The microglial endocannabinoid system similarly regulated by lipopolysaccharide and interferon gamma
capacity of microglia to synthesize, degrade, and respond to cannabinoids which has implications for the development
- VAMP2: a crucial player in the delivery of MOR to the synapse
Through developing a high-resolution method, Hao Chen et al. directly visualized the fusion of vesicles Therefore, their comprehension is essential for developing new treatments for these disorders and advancing
- Trevena Announces Receipt of First $15 million Tranche in Connection with its $40 million ...
(Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel
- A central alarm system that gates multi-sensory innate threat cues to the amygdala
The identification of unified innate threat pathways may provide insights into developing therapeutic
- Primary cilia and SHH signaling impairments in human and mouse models of Parkinson’s disease
Thus, increased SHH activity due to ciliary dysfunction may be required for the development of pathoetiological
- RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. Lübeck, Germany...
So far, numerous therapeutics targeting GPCRs have been developed, with a focus on small molecules and
- Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief ...
(Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization
- Pepducin-mediated G Protein-Coupled Receptor Signaling in the Cardiovascular System
We will discuss the historic context of pepducin development for each receptor, as well as the structural
- Ligands can differentially and temporally modulate GPCR interaction with 14-3-3 isoforms
certain GPCR ligands can regulate GPCR/14-3-3 signals temporally, suggesting a new approach for GPCR drug development
- Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases
treatment of many neurological conditions and several compounds targeting these receptors have been developed
- Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of...
It has begun to play important roles in drug development for complex diseases such as cancer, including
- Orion Shares New Data on its Latest Best-in-Class Drug Candidate
June 2022 "Ottawa, Canada, May 10, 2022 — Orion Biotechnology Canada Ltd, a drug discovery and development
- Crinetics Pharmaceuticals Announces Pricing Of Underwritten Common Stock Offering
(Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization
- Addex Therapeutics Completes Patient Enrollment For Dipraglurant Blepharospasm Phase 2 Clinical ...
, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development
- Drug Discovery Picks Up the Pace, Stays on Target
A project to develop a perfect drug, or a drug that is as safe and effective as possible, may never begin
- Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
artificial intelligence (AI), machine learning, and the design of protein structures in the discovery and development
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
If you work on GPCRs across translational pharmacology, drug development, or molecular pharmacology,
- Mechanistic Understanding of the Palmitoylation of Go Protein in the Allosteric Regulation of...
G-protein-coupled receptors (aGPCRs)-a major family of GPCRs-play critical roles in the regulation of tissue development
- Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone...
regarding the complex biology of the preproglucagon-derived hormones, their signaling, and the drug development
- Therapeutic validation of an orphan G protein‐coupled receptor
shown to play key roles in various physiological functions, such as sensory perception, reproduction, development From these series of compounds, GLPG1205 progressed into clinical development for the potential treatment
- Addex Expands Pipeline With Selective M4 Positive Allosteric Modulator Program For The Treatment ...
, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development
- Targeted Activation of G-Protein Coupled Receptor-Mediated Ca 2+ Signaling Drives Enhanced Cartilage
]i) signaling is a critical regulator of chondrogenesis, chondrocyte differentiation, and cartilage development a CNO dose- and frequency-dependent manner, and triggered the formation of cell condensations that developed
- Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging...
The development of new CB2-related pharmacological and genetic tools, including the first small molecule
- Structural basis for receptor selectivity and inverse agonism in S1P5 receptors
Several S1PR therapeutic drugs have been developed to treat these diseases; however, they lack receptor
- The Bile Acid Membrane Receptor TGR5 in Cancer: Friend or Foe?
regulating proliferation, inflammation, adhesion, migration, insulin release, muscle relaxation, and cancer development
- Addex Raises $10 Million In Equity Financing
, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development
- To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from...
These insights will facilitate further development of therapeutic agents targeting the DOR.Communicated
- Lysine 101 in the CRAC Motif in Transmembrane Helix 2 Confers Cholesterol-Induced Thermal...
in structural biological advancements of GPCRs and design of thermally stabilized receptors for drug development
- G protein-coupled receptor kinase 2 is essential to enable vasoconstrictor-mediated arterial ...
signalling pathways that promote vascular smooth muscle cell (VSMC) proliferation, contributing to the development Considering VSMC GRK2 expression increases early in the development of hypertension, this highlights

